Jubilant Pharmova Profit & Loss Annual

Trade
BSE: 530019 | NSE: JUBLPHARMA | ISIN: INE700A01033 | Sector: Biotechnology & Drugs
743.90 +7.00 (0.95%)Updated : 13 Jun 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 6,702.906,281.736,130.166,098.54
Total Revenue 6,702.906,281.736,130.166,098.54
Costof Revenue Total 2,140.702,222.791,786.991,753.45
Gross Profit 4,562.204,058.944,343.184,345.08
Selling/ General/ Admin Expenses Total 2,216.003,219.053,107.092,850.19
Depreciation/ Amortization 381.90382.60381.70426.07
Unusual Expense( Income) 168.90228.240.0046.81
Other Operating Expenses Total 1,445.4056.0329.93-75.43
Total Operating Expense 6,352.906,108.725,305.715,001.09
Operating Income 350.00173.01824.451,097.44
Interest Inc( Exp) Net- Non- Op Total -2,482.00-1,342.45-1,920.79-2,156.52
Other Net 68.70-8.321.45-4.02
Net Income Before Taxes 170.5027.78630.45871.08
Provisionfor Income Taxes 97.8092.66217.43297.22
Net Income After Taxes 72.70-64.88413.02573.86
Minority Interest 4.403.900.920.26
Net Income Before Extra Items 77.10-60.98413.94574.12
Net Income 77.10-60.98413.94835.87
Income Availableto Com Excl Extra Ord 77.10-60.98413.94574.12
Income Availableto Com Incl Extra Ord 77.10-60.98413.94835.87
Diluted Net Income 77.10-60.98413.94835.87
Diluted Weighted Average Shares 15.8615.9115.9215.93
Diluted EPS Excluding Extra Ord Items 4.86-3.8326.0136.05
DPS- Common Stock Primary Issue 5.005.005.005.00
Diluted Normalized EPS 9.405.6026.1438.26
Gain( Loss)on Saleof Assets --26.58-33.70-66.91
Total Extraordinary Items --0.00261.75
*All figures in crores except per share values
Recommended For You
Trending Stocks
483.30+6.40(1.34%)
1,387.15+16.85(1.23%)
2,495.50-33.50 (-1.32%)
HomeMarketsPremiumFor youGet App